Medical treatment of aortic stenosis: promising, or wishful thinking? (Q44225699)

1 December 2017

0 references

Medical treatment of aortic stenosis: promising, or wishful thinking? (English)

1 reference

1 December 2017

Alan S Pearlman

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

Journal of the American College of Cardiology

1 December 2017

published in

1 reference

1 December 2017

1 reference

1 December 2017

1 reference

1 December 2017

page(s)

1731-1734

1 reference

Evaluation and Management of Patients With Aortic Stenosis

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902497-X

7 January 2021

New insights into the progression of aortic stenosis: implications for secondary prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902497-X

7 January 2021

Are atherosclerotic processes involved in aortic-valve calcification?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902497-X

7 January 2021

Association of coronary risk factors with progression of valvular aortic stenosis in older persons

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902497-X

7 January 2021

Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902497-X

7 January 2021

Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902497-X

7 January 2021

Bone formation and inflammation in cardiac valves

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902497-X

7 January 2021

Effects of intensive lipid-lowering therapy on the coronary arteries of asymptomatic subjects with elevated apolipoprotein B

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902497-X

7 January 2021

Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902497-X

7 January 2021

Hemodynamic progression of aortic stenosis in adults assessed by Doppler echocardiography.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902497-X

7 January 2021

Progression of aortic stenosis in 394 patients: relation to changes in myocardial and mitral valve dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902497-X

7 January 2021

Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902497-X

7 January 2021

Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902497-X

7 January 2021

Factors leading to progression of valvular aortic stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902497-X

7 January 2021

Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902497-X

7 January 2021

Atherosclerosis is an inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902497-X

7 January 2021

Regulation of the mevalonate pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902497-X

7 January 2021

HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902497-X

7 January 2021

Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902497-X

7 January 2021

Why is there discordance between calcific aortic stenosis and coronary artery disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902497-X

7 January 2021

C-reactive protein is increased in patients with degenerative aortic valvular stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902497-X

7 January 2021

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902497-X

7 January 2021

Osteopontin is expressed in human aortic valvular lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902497-X

7 January 2021

HMG-CoA reductase inhibitors and the risk of fractures

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902497-X

7 January 2021

HMG CoA reductase inhibitor (statin) and aortic valve calcium

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902497-X

7 January 2021

10.1016/S0735-1097(02)02497-X

Identifiers

DOI

1 reference

1 December 2017

1 reference